About Interferon alpha/beta receptor 2
Interferon alpha/beta receptor 2 (IFNAR2) is a protein
from Homo sapiens identified by UniProt accession
P48551, 515 residues long.
MolForge cross-references it against 0 known binders and
347 disease associations.
Target properties
| Protein name | Interferon alpha/beta receptor 2 |
| UniProt accession | P48551 |
| Gene | IFNAR2 |
| Organism | Homo sapiens |
| Length | 515 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (347)
Diseases linked to this target (Open Targets).
- COVID-19 · score 0.66
- immunodeficiency 45 · score 0.62
- hepatitis C virus infection · score 0.61
- chronic hepatitis C virus infection · score 0.61
- chronic hepatitis B virus infection · score 0.61
- multiple sclerosis · score 0.60
- neoplasm · score 0.60
- relapsing-remitting multiple sclerosis · score 0.60
- melanoma · score 0.58
- hepatitis B virus infection · score 0.57
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-P48551-F1 | alphafold | PREDICTED | 64.41 | — |
Amino-acid sequence (515 residues)
MLLSQNAFIF RSLNLVLMVY ISLVFGISYD SPDYTDESCT FKISLRNFRS ILSWELKNHS IVPTHYTLLY TIMSKPEDLK VVKNCANTTR SFCDLTDEWR STHEAYVTVL EGFSGNTTLF SCSHNFWLAI DMSFEPPEFE IVGFTNHINV MVKFPSIVEE ELQFDLSLVI EEQSEGIVKK HKPEIKGNMS GNFTYIIDKL IPNTNYCVSV YLEHSDEQAV IKSPLKCTLL PPGQESESAE SAKIGGIITV FLIALVLTST IVTLKWIGYI CLRNSLPKVL NFHNFLAWPF PNLPPLEAMD MVEVIYINRK KKVWDYNYDD ESDSDTEAAP RTSGGGYTMH GLTVRPLGQA SATSTESQLI DPESEEEPDL PEVDVELPTM PKDSPQQLEL LSGPCERRKS PLQDPFPEED YSSTEGSGGR ITFNVDLNSV FLRVLDDEDS DDLEAPLMLS SHLEEMVDPE DPDNVQSNHL LASGEGTQPT FPSPSSEGLW SEDAPSDQSD TSESDVDLGD GYIMR
Explore Interferon alpha/beta receptor 2 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets